Dr. Reddy's Laboratories Limited (BSE: 500124)
Health Care · Pharmaceuticals · IN
Rs1,175.00
-0.54% today · -8.0% 1Y
Dr. Reddy's Laboratories Limited (BSE: 500124) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $10.23B.
Over the last twelve months the share price has lost 8.0%, trading between 1.08K and 1.41K.
Tweenvest scores Dr. Reddy's Laboratories Limited across four factors: quality 83/100, value 54/100, growth 33/100, dividend 22/100. Its strongest factor is quality.
500124 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.23B
- Revenue (TTM)
- $3.50B
- P/E
- 29.58
- EPS
- 39.72
- Dividend yield
- 0.68%
- Beta (5Y)
- 0.24
- 52-week high
- Rs1,414.40
- 52-week low
- Rs1,080.05
- Avg volume (3M)
- —
- Shares outstanding
- 832.98M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,256.59 | +0.09% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.08 | +0.31% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.27 | -0.18% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.30 | -1.41% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.00 | -1.14% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.12 | +0.18% |
Figures last refreshed Aug 18, 2026.